Since DDX5 and DDX17 are known mediators of Wnt signaling in colorectal cancer [10, 11] and DDX3 and DDX5 have been found to interact [12], we evaluated whether RK-33 treatment also influences DDX5 and DDX17 protein levels. The gene discussed is DDX5; the disease is colorectal cancer.